196 related articles for article (PubMed ID: 38609931)
21. Combatting the evolution of antifungal resistance in Cryptococcus neoformans.
Bermas A; Geddes-McAlister J
Mol Microbiol; 2020 Nov; 114(5):721-734. PubMed ID: 32697029
[TBL] [Abstract][Full Text] [Related]
22. Anti-microbial and anti-biofilm activities of combined chelerythrine-sanguinarine and mode of action against Candida albicans and Cryptococcus neoformans in vitro.
Qian W; Yang M; Li X; Sun Z; Li Y; Wang X; Wang T
Colloids Surf B Biointerfaces; 2020 Jul; 191():111003. PubMed ID: 32276211
[TBL] [Abstract][Full Text] [Related]
23. Antifungal Peptide SP1 Damages Polysaccharide Capsule of Cryptococcus neoformans and Enhances Phagocytosis of Macrophages.
Liu Y; Zhang Y; Zhao X; Lu W; Zhong Y; Fu YV
Microbiol Spectr; 2023 Mar; 11(2):e0456222. PubMed ID: 36916981
[TBL] [Abstract][Full Text] [Related]
24. Novel antimicrobial peptide DvAMP serves as a promising antifungal agent against Cryptococcus neoformans.
Yang L; Tian Z; Zhao W; Zhang J; Tian C; Zhou L; Jiao Z; Peng J; Guo G
Bioorg Chem; 2023 Sep; 138():106679. PubMed ID: 37329812
[TBL] [Abstract][Full Text] [Related]
25. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
Yang F; Gritsenko V; Lu H; Zhen C; Gao L; Berman J; Jiang YY
Microbiol Spectr; 2021 Oct; 9(2):e0072321. PubMed ID: 34585947
[TBL] [Abstract][Full Text] [Related]
26. Adenylyl-Sulfate Kinase (Met14)-Dependent Cysteine and Methionine Biosynthesis Pathways Contribute Distinctively to Pathobiological Processes in Cryptococcus neoformans.
Lee SH; Jang YB; Choi Y; Lee Y; Shin BN; Lee HS; Lee JS; Bahn YS
Microbiol Spectr; 2023 Jun; 11(3):e0068523. PubMed ID: 37036370
[TBL] [Abstract][Full Text] [Related]
27. High Prevalence of HIV-Related Cryptococcosis and Increased Resistance to Fluconazole of the
Yang C; Bian Z; Blechert O; Deng F; Chen H; Li Y; Yang Y; Chen M; Zhan P
Front Cell Infect Microbiol; 2021; 11():723251. PubMed ID: 34790585
[TBL] [Abstract][Full Text] [Related]
28. Allicin shows antifungal efficacy against
Li Z; Li Z; Yang J; Lu C; Li Y; Luo Y; Cong F; Shi R; Wang Z; Chen H; Li X; Yang J; Ye F
Front Microbiol; 2022; 13():1012516. PubMed ID: 36466672
[TBL] [Abstract][Full Text] [Related]
29. Repurposing the thrombopoietin receptor agonist eltrombopag as an anticryptococcal agent.
Ko HT; Hsu LH; Yang SY; Chen YL
Med Mycol; 2020 Jun; 58(4):493-504. PubMed ID: 31297540
[TBL] [Abstract][Full Text] [Related]
30. A flucytosine-responsive Mbp1/Swi4-like protein, Mbs1, plays pleiotropic roles in antifungal drug resistance, stress response, and virulence of Cryptococcus neoformans.
Song MH; Lee JW; Kim MS; Yoon JK; White TC; Floyd A; Heitman J; Strain AK; Nielsen JN; Nielsen K; Bahn YS
Eukaryot Cell; 2012 Jan; 11(1):53-67. PubMed ID: 22080454
[TBL] [Abstract][Full Text] [Related]
31. Effect of rapamycin on
de Andrade IB; Alves V; Pereira L; Miranda B; Corrêa-Junior D; Galdino Figueiredo-Carvalho MH; Santos MV; Almeida-Paes R; Frases S
Future Microbiol; 2023 Nov; 18():1061-1075. PubMed ID: 37721517
[TBL] [Abstract][Full Text] [Related]
32. Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts.
Spadari CC; Vila T; Rozental S; Ishida K
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844051
[No Abstract] [Full Text] [Related]
33. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
[TBL] [Abstract][Full Text] [Related]
34. Antifungal activity of peptide MSI-1 against Cryptococcus neoformans infection in vitro and in murine cryptococcal meningoencephalitis.
Ma L; Wei S; Ye X; Xu P; Chen H; Liu Z; Zhou C
Peptides; 2020 Aug; 130():170334. PubMed ID: 32504765
[TBL] [Abstract][Full Text] [Related]
35. Membrane Integrity Contributes to Resistance of Cryptococcus neoformans to the Cell Wall Inhibitor Caspofungin.
Moreira-Walsh B; Ragsdale A; Lam W; Upadhya R; Xu E; Lodge JK; Donlin MJ
mSphere; 2022 Aug; 7(4):e0013422. PubMed ID: 35758672
[TBL] [Abstract][Full Text] [Related]
36. Organoselenium Has a Potent Fungicidal Effect on Cryptococcus neoformans and Inhibits the Virulence Factors.
De Jesus DFF; De Freitas ALD; De Oliveira IM; De Almeida LC; Bastos RW; Spadari CC; Melo ASA; Santos DA; Costa-Lotufo LV; Reis FCG; Rodrigues ML; Stefani HA; Ishida K
Antimicrob Agents Chemother; 2023 Mar; 67(3):e0075922. PubMed ID: 36815840
[TBL] [Abstract][Full Text] [Related]
37. The Cryptococcus neoformans Flc1 Homologue Controls Calcium Homeostasis and Confers Fungal Pathogenicity in the Infected Hosts.
Stempinski PR; Goughenour KD; du Plooy LM; Alspaugh JA; Olszewski MA; Kozubowski L
mBio; 2022 Oct; 13(5):e0225322. PubMed ID: 36169198
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
Martinez LR; Casadevall A
Antimicrob Agents Chemother; 2006 Mar; 50(3):1021-33. PubMed ID: 16495265
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization and antifungal susceptibility testing of Cryptococcus neoformans sensu stricto from southern Brazil.
Herkert PF; Meis JF; Lucca de Oliveira Salvador G; Rodrigues Gomes R; Aparecida Vicente V; Dominguez Muro M; Lameira Pinheiro R; Lopes Colombo A; Vargas Schwarzbold A; Sakuma de Oliveira C; Simão Ferreira M; Queiroz-Telles F; Hagen F
J Med Microbiol; 2018 Apr; 67(4):560-569. PubMed ID: 29461182
[TBL] [Abstract][Full Text] [Related]
40. Genotypic diversity and antifungal susceptibility of Cryptococcus neoformans isolates from paediatric patients in China.
Hong N; Chen M; Xu N; Al-Hatmi AMS; Zhang C; Pan WH; Hagen F; Boekhout T; Xu J; Zou XB; Liao WQ
Mycoses; 2019 Feb; 62(2):171-180. PubMed ID: 30341799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
